Search

everythinglearnresearchcommunity

for

Search:↓

Combining microneedling with triamcinolone acetonide is more effective for treating alopecia areata than microneedling alone.

Patients on dabrafenib and trametinib for melanoma often experience skin side effects.

Pemetrexed with cisplatin is safer and more effective than gemcitabine with cisplatin for advanced lung cancer.

The document concludes that biotin, folate, and RGD peptides are promising for targeting cancer cells with prodrugs, but the conjugates are not yet tested for use.

The topical treatment WR 279,396 effectively healed cutaneous leishmaniasis in mice without relapse.

Using minoxidil and tofacitinib together can effectively treat severe hair loss.

The combined treatment helped prevent hair loss and promoted full hair regrowth in breast cancer patients after chemotherapy.

Two people lost hair unexpectedly after getting a common hair loss treatment with a drug called Dutasteride.

Tacalcitol ointment effectively improves bilateral nevus comedonicus.

Cannabinoids may help treat chronic and chemotherapy-induced neuropathic pain, but more research is needed to confirm their effectiveness and safety.

Finasteride is effective for male hair loss, teledermatology is accurate and accepted, and cyclosporin helps treat toxic epidermal necrolysis.

Talquetamab may cause hair loss and skin issues.

New cancer drugs often cause skin and nail problems.

More research is needed to understand and treat morphea effectively.

Upadacitinib effectively treated a patient with multiple inflammatory conditions.

Tofacitinib is somewhat effective for alopecia areata, but more research is needed on its safety and long-term effects.

Combining traditional Chinese medicine with microneedles shows promise for effectively treating skin diseases with fewer side effects.

Pulsed electric field treatment may help the immune system fight liver tumors.

This therapy effectively treats resistant alopecia areata with minimal side effects.

Luteolin-loaded nanoformulations could improve cancer treatment by enhancing luteolin's effectiveness.

595 nm pulsed dye laser is a cost-effective treatment for nonmelanoma skin cancer with a low recurrence rate.

Using CDK inhibitors on rats showed a reduction in chemotherapy-caused hair loss, but later experiments could not repeat these results.

The combination treatment was more effective for scalp hair regrowth but caused more irritation.

Natural products can help overcome cancer drug resistance.

Indometacin was chosen for a gel to help treat mastopathy and prevent breast cancer.

Topical PUVA can cause temporary hair regrowth in some alopecia areata patients but doesn't change the long-term outcome.

Nanoparticles improve drug delivery and effectiveness in treating inflamed skin.

New cancer treatments are less harmful to hair but can still cause hair loss, color, shape, and growth changes.

Tofacitinib successfully treated hair loss in a Crohn's disease patient who previously used adalimumab.